Myriad Genetics (MYGN) EBITDA (2009 - 2026)
Myriad Genetics (MYGN) EBITDA from Sep 30, 2009 to Mar 31, 2026. The TTM Myriad Genetics (MYGN) EBITDA is -$337M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Myriad Genetics (MYGN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +421.02% |
| 3 Years TTM | +46.10% |
Annual EBITDA change of Myriad Genetics (MYGN)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$18M | -94.54% |
| 2025 | -$334M | +435.31% |
| 2024 | -$62M | -68.13% |
| 2023 | -$196M | +122.41% |
| 2022 | -$88M | -31.17% |
| 2021 | -$128M | +168.84% |
| 2020 | -$48M | +433.71% |
| 2019 | -$8.90M | -227.14% |
| 2018 | $7M | +11.11% |
| 2017 | $6.30M | -57.72% |
| 2016 | $15M | -90.61% |
| 2015 | $159M | -44.97% |
| 2014 | $288M | +21.66% |
| 2013 | $237M | +25.08% |
| 2012 | $189M | +14.78% |
| 2011 | $165M | +16.07% |
| 2010 | $142M | +4.60% |
| 2009 | $136M | N/A |